Aprea Therapeutics, Inc. (APRE) Revenue
Aprea Therapeutics, Inc. (APRE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to APRESource: SEC XBRL filings · For reference only · Not investment advice
More APRE financial trends
APRE Net incomeAPRE Net marginAPRE Gross profitAPRE Gross marginAPRE Operating incomeAPRE Operating marginAPRE Operating cash flowAPRE Free cash flowAPRE Capital expendituresAPRE Return on equityAPRE Stock buybacksAPRE Dividends paidAPRE Total assetsAPRE Total liabilitiesAPRE Shareholders’ equityAPRE overview →